Largest pharmaceuticals by cash on hand

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Veradermics has the lowest figure of the 61 pharmaceuticals ranked by cash on hand, at $21.8M, followed by Oruka Therapeutics ($46.9M) and Dianthus Therapeutics ($51.1M). Figures as of 18 Nov 2026, 15:06 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
61
Lowest
Veradermics$21.8M
Median
$573.3M
Combined market value
$5.13T
Countries
10

Market values as of .

Largest pharmaceuticals by cash on hand
#CompanyCash on hand ↑Market capPriceToday1 yearPrice, 30 daysCountry
1VeradermicsMANE · Health Care$21.8M$5.4B$126.82 0.94% up 233% up United States
2Oruka TherapeuticsORKA · Health Care$46.9M$6.6B$98.01 1.75% up 241% up United States
3Dianthus TherapeuticsDNTH · Health Care$51.1M$5B$87.97 1.14% up 113% up United States
4Rhythm PharmaceuticalsRYTM · Health Care$54.3M$8.1B$116.34 0.24% down 13% up United States
5Edgewise TherapeuticsEWTX · Health Care$61.1M$4.6B$41.58 1.11% down 88% up United States
6ErascaERAS · Health Care$73.8M$4.8B$13.54 2.52% down 403% up United States
7TG TherapeuticsTGTX · Health Care$79.1M$9.7B$63.94 1.96% up 107% up United States
8Spyre TherapeuticsSYRE · Health Care$85.7M$9.1B$95.98 2.31% up 286% up United States
9Travere TherapeuticsTVTX · Health Care$93M$4.9B$50.77 0.64% down 44% up United States
10Corcept TherapeuticsCORT · Health Care$120.5M$7.7B$70.09 0.02% up 8% down United States
11CytokineticsCYTK · Health Care$122.5M$7.3B$52.57 1.78% up 20% down United States
12Protagonist TherapeuticsPTGX · Health Care$128.4M$8.2B$125.98 1.05% up 46% up United States
13Dr. Reddy's LaboratoriesRDY · Health Care$163.5M$12.5B$14.98 1.18% up 5% up India
14Kiniksa Pharmaceuticals InternationalKNSA · Health Care$165.6M$7.6B$96.61 1.58% up 126% up United Kingdom
15Ligand PharmaceuticalsLGND · Health Care$174.9M$5.9B$296.38 0.87% up 43% up United States
16Madrigal PharmaceuticalsMDGL · Health Care$198.7M$9.8B$420.40 0.38% down 24% down United States
17Summit TherapeuticsSMMT · Health Care$225.3M$9.1B$11.35 6.37% up 36% down United States
18Arrowhead PharmaceuticalsARWR · Health Care$226.5M$6.2B$43.74 1.74% up 10% up United States
19Definium TherapeuticsDFTX · Health Care$257.8M$4B$29.55 0.56% up 169% up United States
20Amneal PharmaceuticalsAMRX · Health Care$282M$7.5B$21.52 1.89% up 83% up United States
21Mirum PharmaceuticalsMIRM · Health Care$296.7M$6B$92.02 0.07% up 31% up United States
22Cogent BiosciencesCOGT · Health Care$312M$4.9B$28.35 1.80% up 20% down United States
23Axsome TherapeuticsAXSM · Health Care$322.9M$7.1B$135.06 0.66% down 7% down United States
24Belite BioBLTE · Health Care$352.9M$6.4B$157.94 0.14% up 31% up United States
25Praxis Precision MedicinesPRAX · Health Care$357.3M$8.7B$310.91 1.92% up 61% up United States
26Ionis PharmaceuticalsIONS · Health Care$372.3M$4.6B$27.42 1.70% up 64% down United States
27AlkermesALKS · Health Care$388.6M$7.8B$46.36 1.99% up 58% up Ireland
28InsmedINSM · Health Care$510.4M$26.7B$121.93 0.06% up 40% down United States
29Elanco Animal HealthELAN · Health Care$545M$13.2B$26.32 1.82% up 20% up United States
30BridgeBio PharmaBBIO · Health Care$570.1M$15.1B$77.76 1.25% up 17% up United States
31ABIVAXABVX · Health Care$573.3M$7.4B$83.97 2.27% up 27% down France
32Royalty PharmaRPRX · Health Care$618.7M$39.6B$68.88 0.29% up 78% up United States
33Ascendis PharmaASND · Health Care$683.5M$17.8B$271.25 0.02% up 28% up Denmark
34Legend BiotechLEGN · Health Care$901.9M$3.2B$16.43 1.99% up 42% down United States
35GrifolsGRFS · Health Care$915.3M$5.9B$8.60 0.35% down 1% up Spain
36PTC TherapeuticsPTCT · Health Care$984.6M$5.1B$60.62 0.43% up 20% down United States
37PfizerPFE · Health Care$1.1B$161.3B$28.31 0.58% down 14% up United States
38BioMarin PharmaceuticalBMRN · Health Care$1.3B$11.5B$59.31 1.37% up 11% up United States
39ViatrisVTRS · Health Care$1.3B$23.7B$20.70 1.20% up 96% up United States
40Jazz PharmaceuticalsJAZZ · Health Care$1.4B$15.6B$242.84 0.88% up 37% up Ireland
41Roivant SciencesROIV · Health Care$1.4B$28.4B$39.14 1.11% up 90% up United Kingdom
42United TherapeuticsUTHR · Health Care$1.6B$24.7B$580.40 0.63% down 23% up United States
43Alnylam PharmaceuticalsALNY · Health Care$1.7B$20.9B$156.10 0.26% down 66% down United States
44GenmabGMAB · Health Care$1.7B$31.9B$51.75 0.40% down 70% up Denmark
45ZoetisZTS · Health Care$2.3B$34.1B$83.83 0.41% up 29% down United States
46Regeneron PharmaceuticalsREGN · Health Care$3.1B$99.5B$961.78 0.42% up 36% up United States
47Teva Pharmaceutical IndustriesTEVA · Health Care$3.6B$50B$42.87 0.59% up 74% up Israel
48Takeda PharmaceuticalTAK · Health Care$3.7B$68.7B$21.51 0.60% down 54% up Japan
49Novo NordiskNVO · Health Care$3.9B$177.1B$40.19 1.25% down 17% down Denmark
50GSKGSK · Health Care$4.5B$98.5B$49.15 0.18% down 6% up United Kingdom
51BeOne MedicinesONC · Health Care$4.5B$46.4B$406.38 1.67% down 17% up Switzerland
52Vertex PharmaceuticalsVRTX · Health Care$5.1B$137.2B$541.02 1.28% up 27% up United States
53AbbVieABBV · Health Care$5.2B$514.4B$291.04 0.61% down 26% up United States
54AstraZenecaAZN · Health Care$5.7B$279.8B$180.41 1.02% down 2% up United Kingdom
55Eli LillyLLY · Health Care$7.3B$1.25T$1,401.70 0.98% down 35% up United States
56SanofiSNY · Health Care$8.5B$114.2B$47.56 0.06% up 4% down France
57Abbott LaboratoriesABT · Health Care$8.5B$181.6B$104.87 0.15% up 17% down United States
58Bristol-Myers SquibbBMY · Health Care$10.2B$124B$60.67 1.12% down 34% up United States
59NovartisNVS · Health Care$11.4B$297.1B$157.33 1.13% down 25% up Switzerland
60Merck & CoMRK · Health Care$14.6B$349B$141.55 1.27% down 51% up United States
61Johnson & JohnsonJNJ · Health Care$19.7B$667.3B$277.21 0.53% down 38% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period.

Questions and answers

Which pharmaceuticals have the lowest cash on hand?

Veradermics ($21.8M), Oruka Therapeutics ($46.9M) and Dianthus Therapeutics ($51.1M) have the lowest cash on hand of the 61 pharmaceuticals ranked here as of 18 Nov 2026, 15:06 UTC.

How many pharmaceuticals are in this ranking?

61 are ranked by cash on hand.

What are these pharmaceuticals worth together?

The 61 pharmaceuticals ranked by cash on hand have a combined market value of $5.13T as of 18 Nov 2026, 15:06 UTC.

What does ranking by cash on hand measure?

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Cite this page

Funkfolio, “Largest pharmaceuticals by cash on hand”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=cash-on-hand

Underlying data: Yahoo Finance; SEC EDGAR.